Cargando…
An Update to Returning Genetic Research Results to Individuals: Perspectives of the Industry Pharmacogenomics Working Group
The ease with which genotyping technologies generate tremendous amounts of data on research participants has been well chronicled, a feat that continues to become both faster and cheaper to perform. In parallel to these advances come additional ethical considerations and debates, one of which center...
Autores principales: | Prucka, Sandra K, Arnold, Lester J, Brandt, John E, Gilardi, Sandra, Harty, Lea C, Hong, Feng, Malia, Joanne, Pulford, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305195/ https://www.ncbi.nlm.nih.gov/pubmed/24471556 http://dx.doi.org/10.1111/bioe.12073 |
Ejemplares similares
-
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021) -
A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants
por: Ohneda, Kinuko, et al.
Publicado: (2022) -
Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019) -
Large-scale pharmacogenomic study of sulfonylureas and the QT, JT, and QRS intervals: CHARGE Pharmacogenomics Working Group
por: Floyd, James S, et al.
Publicado: (2016) -
Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)